The New Jersey Cannabis Regulatory Commission is seeking public input on how the state’s medicinal cannabis market can better help patients.

Over the next two months, patients, health care providers, and cannabis business operators are invited to participate in a series of virtual roundtables designed to gather feedback about the state and future of the industry.

According to the CRC, the scheduled sessions include:

• Sept. 5, 11 a.m. to 12:30 p.m.
  The Product Safety, Packaging and Labeling Committee will focus on current purchase limits and elements that may be affecting product prices.
• Sept. 25, 11 a.m. to 12:30 p.m.
  The Public Engagement and Education Committee will explore:
  • • Current limits on vertical integration for medicinal cannabis operators;
    • The number of dispensaries each operator is allowed to own; and
    • The potential for personal-use cannabis business operators to expand into medicinal cannabis.

The Permitting and Licensing Committee will also host roundtables for institutional caregivers Sept. 23 and Oct. 1. Both discussions will run from 11 a.m. to 12:30 p.m. They will address:

• The challenges of becoming an institutional caregiver;
• The support needed to simplify access; and
• Incentives for providers and institutions to become or facilitate institutional caregivers.

An invitation is required to attend the virtual programs. Anyone interested in participating can submit a request at njcrcgov.info/roundtable24

Since the state began adult-use sales in April 2022, the number of enrollees in New Jersey’s medicinal program has declined from 128,548 to the current 75,414. 

CRC Commissioner Krista Nash, co-chair of the PEEC, said feedback from interested parties plays a pivotal role in shaping policies that determine how to serve patients in the market.

“We want to offer an opportunity for health care providers, active patients, federally and non-federally qualified health centers and operational businesses to express their opinions and share valuable feedback on critical issues related to cannabis regulation and the cannabis industry in New Jersey,” Nash said.

See also:

The New Jersey Cannabis Regulatory Commission is also hosting a series of clinics across the state to assist patients and caregivers with signing up or renewing enrollment in the state’s Medicinal Cannabis Program. Click here for the schedule.